Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial
How well does tazemetostat work in treating patients with ovarian, primary peritoneal,
or endometrial cancer that has come back?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This phase II trial studies how well tazemetostat works in treating patients with
ovarian, primary peritoneal, or endometrial cancer that has come back. Drugs used
in chemotherapy, such as tazemetostat, work in different ways to stop the growth of
tumor cells, either by killing the cells, by stopping them from dividing, or by stopping
them from spreading.
Study Reference #: CGYE19064
Lead Researcher (Principal Investigator)
Lead Researcher: Richard Moore
Study Contact InformationStudy Coordinator: Laura Mitchell
Phone: (585) 275-7763
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search